SYNDROS is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Benuvia Therapeutics Inc.. The primary component is Dronabinol.
| Product ID | 78613-201_47babd53-3b15-4b73-ab66-32d4b304bb6b |
| NDC | 78613-201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SYNDROS |
| Generic Name | Dronabinol |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-07-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205525 |
| Labeler Name | Benuvia Therapeutics Inc. |
| Substance Name | DRONABINOL |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | Cannabinoid [EPC],Cannabinoids [CS] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2017-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 20482-335 | SYNDROS | SYNDROS |
| 78613-201 | SYNDROS | SYNDROS |
| 0527-1450 | Dronabinol | Dronabinol |
| 0527-1451 | Dronabinol | Dronabinol |
| 0527-1452 | Dronabinol | Dronabinol |
| 0527-4125 | DRONABINOL | dronabinol |
| 0591-3591 | Dronabinol | Dronabinol |
| 0591-3592 | Dronabinol | Dronabinol |
| 0591-3593 | Dronabinol | Dronabinol |
| 0904-6597 | Dronabinol | Dronabinol |
| 0904-6598 | Dronabinol | Dronabinol |
| 0904-6745 | DRONABINOL | DRONABINOL |
| 0904-6746 | DRONABINOL | DRONABINOL |
| 0904-7068 | Dronabinol | Dronabinol |
| 0904-7144 | Dronabinol | Dronabinol |
| 0904-7145 | Dronabinol | Dronabinol |
| 17478-761 | Dronabinol | Dronabinol |
| 17478-762 | Dronabinol | Dronabinol |
| 17478-763 | Dronabinol | Dronabinol |
| 0051-0021 | Marinol | Dronabinol |
| 0051-0022 | Marinol | Dronabinol |
| 0051-0023 | Marinol | Dronabinol |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SYNDROS 86360360 5286618 Live/Registered |
FRESH CUT DEVELOPMENT, LLC 2014-08-07 |